Intraoperative application of topical mitomycin C 0.05% for pterygium surgery

Bol Asoc Med P R. 2004 Mar-Apr;96(2):100-2.

Abstract

Background: Pterygium recurrence is a common problem encountered by ophthalmic surgeons. Several methods have been suggested to avoid these recurrences. We studied the recurrence rate of pterygium after administration of a single intraoperative dosage of topical mitomycin C 0.05%.

Methods: A retrospective analysis of fifty eyes in forty-nine patients who underwent pterygium excision by the same surgeon using intraoperative topical mitomycin C during the years 2002--2003. Mitomycin concentration was 0.05% applied to pterygium and adjacent areas after undermining and separation from sclera but prior to excision for three minutes. Postoperative follow up time was 12 months.

Results: The pterygium recurred in 4 (8%) eyes. Another four eyes (8%) had a cosmetically acceptable recurrence of < 2.0 mm. The only complication was a corneal dellen in one eye.

Conclusion: Intraoperative administration of mitomycin C at 0.05% is safe and effective in preventing pterygium recurrences.

Publication types

  • Review

MeSH terms

  • Administration, Topical
  • Adult
  • Aged
  • Alkylating Agents / administration & dosage
  • Alkylating Agents / therapeutic use*
  • Combined Modality Therapy
  • Dexamethasone / administration & dosage
  • Dexamethasone / therapeutic use
  • Female
  • Humans
  • Instillation, Drug
  • Intraoperative Care
  • Male
  • Middle Aged
  • Mitomycin / administration & dosage
  • Mitomycin / therapeutic use*
  • Ointments
  • Pterygium / drug therapy*
  • Pterygium / surgery
  • Recurrence
  • Retrospective Studies
  • Tobramycin / administration & dosage
  • Tobramycin / therapeutic use

Substances

  • Alkylating Agents
  • Ointments
  • Mitomycin
  • Dexamethasone
  • Tobramycin